approval
savePONLIMSI (DENOSUMAB-ADET) — FDA approval
community read0 votes
Sponsor: TEVA PHARMACEUTICALS, INC.. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 1, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 1, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Apr 1, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Mar 11, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Mar 11, 2026
- recallTeva Pharmaceuticals USA, Inc recall (Cls II)Mar 11, 2026
comments(0)
5-min edit window · permanent after that